Outcomes of a High-Volume Organ Procurement Organization in the Era of Increasing Donation After Circulatory Death

Mark J Hobeika1,2,3, Terri Menser1,2,3,4, Kevin Myer5

  • 1J.C. Walter, Jr. Transplant Center and Department of Surgery, 23530Houston Methodist, Houston, TX, USA.

Progress in Transplantation (Aliso Viejo, Calif.)
|September 5, 2022
PubMed

Insights

Donation after circulatory death (DCD) organ utilization can be improved by standardizing processes and policies. Factors like pre-mortem heparin and shorter warm ischemia times enhance DCD organ transplantation success.

Area of Science:

  • Organ transplantation research
  • Public health policy
  • Medical process evaluation

Background:

  • Donation after circulatory death (DCD) is a growing organ donation pathway in the US.
  • Comprehensive data on the DCD referral to transplantation process is limited.
  • Understanding donor type differences is crucial for optimizing organ utilization.

Purpose of the Study:

  • To quantify differences in the donation pathway stages by donor type.
  • To identify factors associated with successful DCD organ utilization.
  • To examine the role of first-person authorization in DCD.

Main Methods:

  • Program evaluation of data from a single organ procurement organization in 2018.
  • Analysis of demographic and clinical predictors of donation process progression.
  • Logistic regression models to assess predictors of utilization and authorization.

Main Results:

  • Differences in authorization rates were observed between DCD and donation after brainstem death (DBD) donors, influenced by age, race, and ethnicity.
  • Next-of-kin refusal occurred in 23% of first-person authorized DCD cases.
  • Pre-mortem heparin administration, donor age, and warm ischemia time <30 min predicted DCD organ utilization.

Conclusions:

  • Findings offer strategies to increase DCD organ authorization and transplantation rates.
  • Identified areas for process standardization and policy development in DCD donation.
  • Highlights the importance of donor registration and authorization in DCD.

Related Concept Videos

Kidney Transplant I: Introduction01:28

Kidney Transplant I: Introduction

A kidney transplant is a surgical approach that involves replacing a non-functioning kidney with a healthy one from a donor. This procedure is often a treatment option for end-stage renal disease (ESRD) patients. The method requires careful recipient selection, including evaluating various medical and psychosocial factors. These criteria vary between transplant centers but generally include assessments of the patient's overall health, adherence to medical recommendations, and lifestyle...
50
Tissue Transplantation01:24

Tissue Transplantation

Tissue transplantation is a significant medical procedure involving the transfer of cells, tissues, or organs from a donor to a recipient, with the primary aim of restoring lost functions. This procedure is crucial in treating a broad spectrum of diseases, including kidney diseases, liver failure, heart disease, and certain types of cancers.
The Biology of Tissue Transplantation
The biology of tissue transplantation hinges on the Major Histocompatibility Complex (MHC) molecules. These molecules...
503
Kidney Transplant II: Surgical Procedure01:26

Kidney Transplant II: Surgical Procedure

Preoperative ManagementThe primary goals of preoperative management in kidney transplantation are to optimize the patient’s metabolic state and prepare them for surgery through diet adjustments, necessary dialysis, and tailored medical treatment. This phase also involves comprehensive infection screening and patient education about the surgical procedure and postoperative care to improve outcomes and adherence.Medical ManagementA comprehensive evaluation is required for both the living...
65